Randomized Prospective Trial Comparing Intralipid Versus SMOFlipid in New HPN Patients.

Status: Recruiting
Location: See location...
Intervention Type: Dietary Supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will randomize all patients who are new to the Mayo Clinic HPN team to either standard lipid emulsion (Intralipid) or SMOFLipid.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: No
View:

• Newly initiated Mayo Clinic HPN patient

• Able to provide informed consent

• Anticipated duration of HPN greater than 3 months,

• Infusion company is able to provide Smoflipid

Locations
United States
Minnesota
Mayo Clinic in Rochester
Recruiting
Rochester
Contact Information
Primary
Manpreet S Mundi, MD
Mundi.Manpreet@mayo.edu
507-284-4080
Backup
Vishakantha (Vishu) Murthy, PhD
Murthy.Vishakantha@mayo.edu
507-255-8112
Time Frame
Start Date: December 31, 2018
Estimated Completion Date: December 2022
Participants
Target number of participants: 100
Treatments
Active Comparator: SMOFLipid
SMOFlipid is a lipid emulsion that contains a combination of soybean oil, medium chain triglycerides, olive oil, and fish oil.
Active Comparator: IntraLipid
Intralipid is a lipid emulsion that contains soybean oil
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov